Research Article
Role of Membrane Lipids in the Regulation of Erythrocytic Oxygen-Transport Function in Cardiovascular Diseases
Table 2
Distribution of erythrocytes sizes in the course of SA patients’ treatment and healthy persons (means ± SD).
| Patients groups | Indicators | Phase image area of erythrocyte, , µm2 | Erythrocyte volume, , µm3 | The mean value of optical path difference (OPD), , |
| Donors | 110.92 ± 0.54 | 89.43 ± 3.63 | 60.92 ± 2.36 | SA patients before treatment | 87.35 ± 3.01 | 126.29 ± 3.15 | 108.44 ± 2.28 | SA+HT patients before treatment | 92.32 ± 4.77 | 109.21 ± 3.61 | 88.72 ± 4.30 | SA patients after treatment | 99.44 ± 2.45 | 118.47 ± 2.68 | 89.35 ± 1.92 | SA+HT patients after treatment | 101.30 ± 1.95 | 108.88 ± 2.04 | 80.61 ± 1.51 |
|
|
Reliability in relation to donors’ indicators. Reliability in relation to pretreatment indicators at .
|